[1] CHAVADA R, GHOSH N, SANDARADURA I, et al.Towards individualised vancomycin dosing in Methicillin-resistant Staphylococcus aureus bacteraemia: establishment of an AUC 0-24 threshold for nephrotoxicity[J]. Antimicrob Agents Chemother, 2017, 61(5): e02535-16. [2] Clinical use of vancomycin:an expert consensus in China(2011)[J]. Chinese Journal of New Drugs and Clinical Remedies(中国新药与临床杂志), 2011, 30(8): 561-573. [3] LIU C, BAYER A, COSGROVE SE, et al.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children[J]. Clinical Infectious Diseases, 2011, 52(3): 285-292. [4] KHWAJA A.KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4): c179-c184. [5] LI GH.Chinese expert consensus on clinical application dose of vancomycin[J]. Chinese Journal of Infectious Diseases(中华传染病杂志), 2012, 30(11): 641-646. [6] XU JW, HUANG PF, LIN HF, et al.Analysis of influencing factors and distribution on vancomycin trough concentration in patients with normal renal functions[J]. Chinese Journal of Antibiotics(中国抗生素杂志), 2020, 45(2): 199-203. [7] YU Z, LIU G, ZHAO HY, et al.Serum concentration monitoring and analysis of vancomycin at 2015 in Peking University People’s Hospital[J]. Clinical Medication Journal(临床药物治疗杂志), 2016, 14(6): 27-29. [8] WANG QY, HE J, WANG JJ, et al.Analysis of the clinical efficacy and nephrotoxicity of vancomycin at high and low trough concentrations in elderly patients in our hospital[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2018, 38(9): 965-968. [9] LIAN X, LIN XF, LI HN, et al.Analysis of serum concentration monitoring and clinical application of vancomycin in 173 cases[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2018, 38(17): 1823-1827. [10] HE J, WANG QY, WANG JJ, et al.Analysis of blood drug concentration of vancomycin in elderly patients and discussion on dosage regimen[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2018, 38(6): 630-633. [11] LUO WW, ZHU CX, ZHANG HY.Analysis of serum vancomycin concentration monitoring and pharmaceutical care in 85 cases[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2015, 35(12): 1142-1146. [12] JEFFRES MN, ISAKOW W, DOHERTY JA, et al.A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia[J].Clin Ther, 2007, 29(6): 1107-1115. [13] YIN YY, ZHU J, JIANG L.Analysis of related factors of Vancomycin concentration not up to standard in ICU[J]. China Medical Herald(中国医药导报), 2018, 15(21): 110-113. [14] WANG CH, HE N, SU S, et al.Vancomycin administration in patients with renal replacement therapy:a systematic review[J]. Clinical Medication Journal(临床药物治疗杂志), 2021, 19(5): 61-65. [15] GE J, DING Y, GUAN Y, et al.Analysis of the influence of blood concentration monitoring of vancomycin in children with hypoproteinemia[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2020, 40(12): 1360-1363. [16] HALL RGI, BLASZCZYK AT, THOMPSON KA, et al.Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia[J]. J Clin Pharm Ther, 2014, 39(6): 653-657. [17] FANG L, XIA Q, WANG YY, et al.Clinical application and serum concentration monitoring of vancomycin:analysis of 256 cases[J]. Anhui Medical and Pharmaceutical Journal(安徽医药), 2019, 23(7):1468-1472. |